QuantumScape is getting closer to commercializing its solid-state EV battery technology, and the market could be huge. 2025 has been a good year for
Latest News
Gold vs silver: With rupee at 90 and Fed decision due, which metal has more steam left?
He added that the momentum could push silver prices towards Rs 2,00,000-2,25,000 levels in the short term. Gold prices are likely to remain firm
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck (MRK 1.16%) has taken its shareholders on a wild ride of late — from last March’s record high of more than $130 to
Greenman Open takes a breather but, as Ivan Yates told us, investments can go either way
Overheard gets all its best investment ideas from ads on political podcasts. Only this week did we realise that this might not be the
Bitcoin Faces Japan Rate Hike: Yen Carry Trade Unwind Fears Miss the Mark, Real Risk Elsewhere
With the Bank of Japan (BOJ) expected to hike rates next week, some observers are worried that the Japanese yen could surge, triggering an
Ukraine’s Black Sea attacks trigger surge in shipping insurance prices
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be
BST: Technology Options CEF With 7.3% Yield, Growth, No Leverage, But Volatility
This article was written by 58.57K Followers Financially Free Investor is a financial writer with 25 years investment experience. He focuses on investing in
Breaking down the trade: What do the Red Sox see in Johan Oviedo?
In the two weeks preceding MLB’s annual Winter Meetings in Orlando, the Boston Red Sox swung trades for a pair of right-handed starting pitchers.
4 Things to Watch With DECK Stock in 2026
Deckers Outdoor has had a disastrous 2025. Can it bounce back next year? To say 2025 has been a disappointment for Deckers Outdoor (DECK
Which Is a Better Investment, Aurinia Pharmaceuticals Inc. or Twist Bioscience Corporation Stock?
Featured Tickers: Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge